Yi Zhe Wang
Geen lopende functies
Vermogen: - $ op 31-03-2024
Profiel
Yi Zhe Wang served as the Chief Executive Officer & Director at LianBio from 2021 to 2023.
Prior to that, he was the Senior VP-BioMedicines & Oncology Businesses at Lilly China Research & Development Co. Ltd.
from 2018 to 2020.
Wang holds a doctorate from Yale University, an undergraduate degree from Ramapo College of New Jersey, and an MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LIANBIO
-.--% | 10-04-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Eerdere bekende functies van Yi Zhe Wang
| Bedrijven | Functie | Einde |
|---|---|---|
| LIANBIO | Chief Executive Officer | 16-12-2023 |
Lilly China Research & Development Co. Ltd.
 Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The private company is based in Shanghai, China. | Corporate Officer/Principal | 01-05-2020 |
Opleiding van Yi Zhe Wang
| Yale University | Doctorate Degree |
| Ramapo College of New Jersey | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LIANBIO | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Lilly China Research & Development Co. Ltd.
Lilly China Research & Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Lilly China Research & Development Co., Ltd. is a Chinese company that engages in the discovering and developing of diabetes medicines. The private company is based in Shanghai, China. | Health Technology |
